Introduction: The Y chromosome, essential for male sex determination and reproduction, has undergone significant evolutionary shrinkage, losing most of its genetic content. This review explores the biological and historical significance of the Y chromosome, its role in male-specific traits, spermatogenesis, and secondary sexual characteristics. It also examines the implications of its shrinking for male infertility, cancer risk, and aging-related diseases, along with potential pharmacological and genetic solutions Method: A comprehensive review of existing literature, cross-species studies, and recent advancements in genetics and medical research was conducted. Based on mechanisms of Y chromosome degeneration, its impact on health, and possible therapeutic interventions, including hormone replacement therapies, assisted reproductive technologies, and geneediting techniques like CRISPR. Results: Despite reducing from 1,400 to 55 active genes, the Y chromosome retains key functions in testosterone production and sperm maturation through genes like SRY, DAZ, and TSPY. Studies suggest alternative mechanisms for male traits in the absence of the Y chromosome, raising questions about its future in humans. Discussion: The shrinkage is linked to infertility, increased cancer risk, and aging-related disorders. Potential pharmacological approaches involve hormone replacement therapies, assisted reproductive technologies, and gene-editing techniques like CRISPR. Conclusion: The shrinking Y chromosome poses challenges to male health, but scientific advancements offer hope for mitigating its effects. Integrating genetic research, evolutionary studies, and medical innovations is crucial for addressing Y-linked disorders and guiding the future of male health and reproduction.
Sahu et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: